BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16953682)

  • 1. Syringocystadenoma papilliferum: a rare breast tumor in a young boy.
    Vaos G; Pierrakou P
    Pediatr Dev Pathol; 2006; 9(5):381-3. PubMed ID: 16953682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syringocystadenoma papilliferum associated with apocrine poroma.
    Suzuki T; Ikeda H; Hamasaki Y; Hatamochi A; Yamazaki S
    J Dermatol; 2006 Apr; 33(4):249-51. PubMed ID: 16674787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syringocystadenoma papilliferum of the eyelid.
    Perlman JI; Urban RC; Edward DP; Tso MO
    Am J Ophthalmol; 1994 May; 117(5):647-50. PubMed ID: 8172272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syringocystadenoma papilliferum on the male nipple.
    Shindo M; Yamada N; Yoshida Y; Yamamoto O; Morino S
    J Dermatol; 2011 Jun; 38(6):593-6. PubMed ID: 21914158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous leiomyosarcoma, trichoblastoma, and syringocystadenoma papilliferum arising from nevus sebaceus.
    Premalata CS; Kumar RV; Malathi M; Shenoy AM; Nanjundappa N
    Int J Dermatol; 2007 Mar; 46(3):306-8. PubMed ID: 17343592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands.
    Nishie W; Sawamura D; Mayuzumi M; Takahashi S; Shimizu H
    J Cutan Pathol; 2004 Sep; 31(8):561-4. PubMed ID: 15268713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agminated syringocystadenoma papilliferum: a new clinical presentation of a rare benign adnexal neoplasm.
    Ogunrinade K; Blobstein SH; Desman GT
    Dermatol Online J; 2013 Aug; 19(8):19270. PubMed ID: 24021448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands: report of a case and review of the literature.
    Parks A; Branch KD; Metcalf J; Underwood P; Young J
    Am J Dermatopathol; 2012 Feb; 34(1):104-9. PubMed ID: 22262361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubular apocrine adenoma in association with syringocystadenoma papilliferum.
    Aktepe F; Demir Y; Dilek FH
    Dermatol Online J; 2003 Feb; 9(1):7. PubMed ID: 12639465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringocystadenoma papilliferum of the male breast.
    Nowak M; Pathan A; Fatteh S; Fatteh S; Lopez J
    Am J Dermatopathol; 1998 Aug; 20(4):422-4. PubMed ID: 9700386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syringocystadenoma papilliferum: report of 8 cases.
    Rammeh-Rommani S; Fezaa B; Chelbi E; Kammoun MR; Ben Jilani SB; Zermani R
    Pathologica; 2006 Jun; 98(3):178-80. PubMed ID: 17036946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syringocystadenoma papilliferum with sebaceous differentiation in an intradermal tubular apocrine component. Report of a case.
    Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
    Am J Dermatopathol; 2008 Feb; 30(1):51-3. PubMed ID: 18212545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tubulo-papillary apocrine adenoma in association with syringocystadenoma papilliferum].
    Ayadi L; Mallouli M; Kallel R; Charfi S; Makni S; Boudawara TS; Gouiaa N
    Ann Pathol; 2016 Oct; 36(5):355-357. PubMed ID: 27693311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary apocrine carcinoma associated with apocrine adenoma and apocrine gland hyperplasia.
    Bujas T; Pavić I; Lenicek T; Mijić A; Kruslin B; Tomas D
    Acta Dermatovenerol Croat; 2007; 15(3):148-51. PubMed ID: 17868540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Syringocystadenoma papilliferum. A case located on the knee].
    Ndiaye B; Kane A; Develoux M; Dieng MT; Saccharin C
    Ann Dermatol Venereol; 1994; 121(4):323-4. PubMed ID: 7702252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual complex cutaneous adnexal tumor composed of syringocystadenoma papilliferum, apocrine hidrocystoma, and clear cell syringoma.
    Lin WL; Lin WC; Kuo TT; Chen CH; Hong HS
    Dermatol Surg; 2007 Jul; 33(7):876-9. PubMed ID: 17598859
    [No Abstract]   [Full Text] [Related]  

  • 17. Morphologic diversity of syringocystadenocarcinoma papilliferum based on a clinicopathologic study of 6 cases and review of the literature.
    Kazakov DV; Requena L; Kutzner H; Fernandez-Figueras MT; Kacerovska D; Mentzel T; Schwabbauer P; Michal M
    Am J Dermatopathol; 2010 Jun; 32(4):340-7. PubMed ID: 20216201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringocystadenoma papilliferum of the male nipple.
    Kasashima S; Kawashima A; Fujii T
    J Cutan Pathol; 2016 Aug; 43(8):679-83. PubMed ID: 26269194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital syringocystadenoma papilliferum.
    Karg E; Korom I; Varga E; Ban G; Turi S
    Pediatr Dermatol; 2008; 25(1):132-3. PubMed ID: 18304179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine needle aspiration cytology of chondroid syringoma and syringocystadenoma papilliferum. A report of two cases.
    Srinivasan R; Rajwanshi A; Padmanabhan V; Dey P
    Acta Cytol; 1993; 37(4):535-8. PubMed ID: 8392255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.